Paul Chaney

Biography

Paul Chaney is president and CEO of PanOptica, Inc., a start-up, venture-backed private biopharma company, with a mission to develop innovative ophthalmic therapeutics. Prior to co-founding PanOptica, Paul was executive vice president of OSI Pharmaceuticals and president of (OSI) Eyetech, OSI’s eyecare subsidiary. He joined Eyetech Pharmaceuticals as chief operating officer in 2003. Paul has nearly 30 years of experience in the pharmaceutical industry, including a variety of senior management positions at Pharmacia Corporation. At Pharmacia, Paul served as vice president of the Global Ophthalmology Business and as vice president of Global Pharmaceutical Ophthalmology. He began his career as a sales representative for The Upjohn Company in 1980. Paul earned a dual degree in Biological Sciences and English from the University of Delaware. 

Research Interest

Eye diseases, vision loss, effective treatments for sight-threatening diseases, licensing and developing innovative therapeutics, diabetic retinopathy, wet age-related macular degeneration